|
GB935962A
(en)
|
1960-06-17 |
1963-09-04 |
Fujisawa Pharmaceutical Co |
Improvements in or relating to the production of 6.8-dithiooctanamides
|
|
US3855240A
(en)
|
1969-04-28 |
1974-12-17 |
Exxon Research Engineering Co |
Sulfur containing heterocycles
|
|
US4210667A
(en)
|
1979-04-19 |
1980-07-01 |
Pfizer Inc. |
Pharmaceutical preparations containing coumarin carboxylic acid derivatives
|
|
US4755528A
(en)
|
1984-12-06 |
1988-07-05 |
Alcon Laboratories, Inc. |
High energy ionizing protective 2,3-diamino-1,4-butanedithiol; 4,5-diamino-1,2-dithiane; and N-acyl and N-alkyl derivatives thereof, compositions and method of use therefor
|
|
US6030950A
(en)
|
1987-07-09 |
2000-02-29 |
Ohlenschlaeger; Gerhard |
Pharmaceutical therapeutic use of glutathione derivative
|
|
US5599903A
(en)
|
1992-04-03 |
1997-02-04 |
Terrapin Technologies, Inc. |
Glutathione analogs and paralog panels comprising glutathione mimics
|
|
FR2638970A1
(fr)
|
1988-11-16 |
1990-05-18 |
Corbiere Jerome |
Nouvelles compositions pharmaceutiques agissant sur la presbytie et leur procede d'obtention
|
|
WO1993002639A1
(en)
|
1991-08-06 |
1993-02-18 |
Autogenesis Technologies, Inc. |
Injectable collagen-based compositions for making intraocular lens
|
|
US5466680A
(en)
|
1992-03-26 |
1995-11-14 |
Cytologics, Inc. |
Method and compositions for enhancing white blood cell functioning on a mucosal or cutaneous surface
|
|
US5459133A
(en)
|
1992-06-05 |
1995-10-17 |
Telor Ophthalmic Pharmaceuticals, Inc. |
Methods and products for treating presbyopia
|
|
WO1993025166A1
(en)
|
1992-06-10 |
1993-12-23 |
Summit Technology, Inc. |
Correction of presbyopia by photorefractive keratectomy
|
|
WO1994001096A1
(en)
|
1992-07-02 |
1994-01-20 |
Telor Ophthalmic Pharmaceuticals, Inc. |
Methods and products for treating presbyopia
|
|
JPH08505119A
(ja)
|
1992-07-06 |
1996-06-04 |
バイオミラ、インコーポレーテッド |
接合目的のためのタンパク質の光活性化
|
|
US5354331A
(en)
|
1992-07-15 |
1994-10-11 |
Schachar Ronald A |
Treatment of presbyopia and other eye disorders
|
|
US5465737A
(en)
|
1992-07-15 |
1995-11-14 |
Schachar; Ronald A. |
Treatment of presbyopia and other eye disorders
|
|
BR9306848A
(pt)
|
1992-08-07 |
1998-12-08 |
Keravision Inc |
Anel polimérico dividido para introdução no estroma
|
|
DE4345199C2
(de)
*
|
1993-05-22 |
1995-10-12 |
Asta Medica Ag |
Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe
|
|
US5395356A
(en)
|
1993-06-04 |
1995-03-07 |
Summit Technology, Inc. |
Correction of presbyopia by photorefractive keratectomy
|
|
US5527774A
(en)
|
1993-07-12 |
1996-06-18 |
Girard; Louis J. |
Dislocation of cataractous lens by enzymatic zonulolysis
|
|
US5665770A
(en)
|
1993-11-05 |
1997-09-09 |
Gakko Hojin Kinki Daigaku |
Method for treatment of cataract with radical scavenger
|
|
CA2185699A1
(en)
|
1994-04-04 |
1995-10-12 |
William R. Freeman |
Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
|
|
US6063116A
(en)
|
1994-10-26 |
2000-05-16 |
Medarex, Inc. |
Modulation of cell proliferation and wound healing
|
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
|
US5624955A
(en)
|
1995-05-03 |
1997-04-29 |
Regents Of The University Of Minnesota |
Compounds that enhance the concentration of glutathione in tissues
|
|
US5686450A
(en)
|
1995-06-07 |
1997-11-11 |
Alcon Laboratories, Inc. |
Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
|
|
US6007510A
(en)
|
1996-10-25 |
1999-12-28 |
Anamed, Inc. |
Implantable devices and methods for controlling the flow of fluids within the body
|
|
US5817630A
(en)
|
1997-03-18 |
1998-10-06 |
Austin Nutriceutical Corporation |
Glutathione antioxidant eye drops
|
|
IL123887A0
(en)
|
1997-04-02 |
1998-10-30 |
Sankyo Co |
Dithiolan derivatives their use and pharmaceutical compositions containing the same
|
|
US5843184A
(en)
|
1998-01-26 |
1998-12-01 |
Cionni; Robert J. |
Endocapsular tension ring and method of implanting same
|
|
US6153647A
(en)
|
1998-11-12 |
2000-11-28 |
My-Tech, Inc. |
Method for augmenting the inotropic effects of β-adrenergic agonists using pyruvate therapy
|
|
US6472541B2
(en)
|
1998-11-20 |
2002-10-29 |
The Regents Of The University Of California |
Protecting groups with increased photosensitivities
|
|
WO2000032235A1
(de)
|
1998-11-26 |
2000-06-08 |
Pentapharm Ag |
Transportsystemkonjugate
|
|
US6288106B1
(en)
|
1999-05-25 |
2001-09-11 |
Chronorx, Llc |
Processes for the synthesis and use of various α-lipoic acid complexes
|
|
US6339102B1
(en)
|
1999-06-09 |
2002-01-15 |
The United States Of America As Represented By The Secretary Of The Army |
Method and composition for treating and preventing retinal damage
|
|
JP4476435B2
(ja)
*
|
1999-07-22 |
2010-06-09 |
株式会社細川洋行 |
仕切部材、複室輸液容器および薬剤入り複室輸液容器の製造方法
|
|
US6890896B1
(en)
|
1999-11-18 |
2005-05-10 |
Ceremedix, Inc. |
Compositions and methods for counteracting effects of reactive oxygen species and free radicals
|
|
US6387945B2
(en)
|
2000-04-11 |
2002-05-14 |
The Regents Of The University Of California |
Lipoic acid analogs
|
|
EP1303215A1
(en)
|
2000-07-10 |
2003-04-23 |
Koninklijke Philips Electronics N.V. |
Geometry matching for imaging medical apparatus
|
|
AU2001291677A1
(en)
|
2000-08-02 |
2002-02-13 |
Basf Aktiengesellschaft |
Method for producing lipoic acid and dihydrolipoic acid
|
|
US7935332B2
(en)
|
2000-08-16 |
2011-05-03 |
Encore Health, Llc |
Presbyopia treatment by lens alteration
|
|
US8697109B2
(en)
|
2000-08-16 |
2014-04-15 |
Encore Health, Llc |
Caged mercaptan and seleno-mercaptan compounds and methods of using them
|
|
US8647612B2
(en)
|
2008-03-05 |
2014-02-11 |
Encore Health, Llc |
Dithiol compounds, derivatives, and treatment of presbyopia
|
|
US20050112113A1
(en)
|
2000-08-16 |
2005-05-26 |
Till Jonathan S. |
Presbyopia treatment by lens alteration
|
|
US7914815B2
(en)
|
2000-08-16 |
2011-03-29 |
Encore Health, Llc |
Method for delivery of pharmaceuticals for treating or preventing presbyopia
|
|
US6923955B2
(en)
|
2000-08-16 |
2005-08-02 |
Newlens, Llc |
Presbyopia treatment by lens alteration
|
|
WO2002013863A2
(en)
|
2000-08-16 |
2002-02-21 |
Refocus, Llc. |
Presbyopia treatment by lens alteration
|
|
DE10045059A1
(de)
|
2000-09-12 |
2002-03-21 |
Basf Ag |
Therapeutische Kombination von Liponsäure und Konjuensäuren zur Behandlung diabetischer Störungen
|
|
US6273092B1
(en)
|
2000-09-22 |
2001-08-14 |
Gerard M. Nolan |
Methods for treating various eye disorders
|
|
US6703039B2
(en)
|
2000-12-06 |
2004-03-09 |
Bausch & Lomb Incorporated |
Reversible gelling system for ocular drug delivery
|
|
EP1808158A3
(en)
|
2001-01-19 |
2008-06-18 |
Newlens, LLC |
Presbyopia treatment by lens alteration
|
|
ATE446949T1
(de)
|
2001-03-19 |
2009-11-15 |
Senju Pharma Co |
Neues a-liponsäurederivat und dessen verwendung
|
|
CA2448062A1
(en)
|
2001-05-25 |
2002-12-05 |
Ceremedix, Inc. |
Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
|
|
FR2832637B1
(fr)
|
2001-06-07 |
2004-07-30 |
Lefaix Marie Therese Droy |
Utilisation d'un antioxydant pour la fabrication d'un medicament destine au traitement des affections oculaires de surface
|
|
ITMI20011232A1
(it)
|
2001-06-12 |
2002-12-12 |
St Microelectronics Srl |
Metodo di riprogrammazione successiva ad una operazione di cancellazione di una matrice di celle di memoria non volatile, in particolare di
|
|
AU2002254546A1
(en)
|
2002-04-03 |
2003-10-20 |
Mitchell A. Avery |
Lipoic acid analogs useful as provitamins and antioxidants
|
|
US20050137124A1
(en)
|
2002-08-09 |
2005-06-23 |
Vitreo-Retinal Technologies, Inc. A California Corporation |
Agents for intravitreal administration to treat or prevent disorders of the eye
|
|
AU2003264412A1
(en)
|
2002-09-13 |
2004-04-30 |
Oga Research, Incorporated |
Melanin extinguisher
|
|
WO2004028536A1
(en)
*
|
2002-09-30 |
2004-04-08 |
Babizhayev Mark A |
Method for topical treatment of eye disease and composition and device for said treatment
|
|
US20060177430A1
(en)
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
|
US7941211B2
(en)
|
2003-11-17 |
2011-05-10 |
Zeavision, Llc. |
Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders
|
|
US7585846B2
(en)
|
2003-11-25 |
2009-09-08 |
University Of Rochester |
Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
|
|
US7718697B2
(en)
|
2003-12-17 |
2010-05-18 |
Alcon, Inc. |
Method for treating glaucoma comprising administering α-lipoic acid
|
|
GB0404693D0
(en)
|
2004-03-02 |
2004-04-07 |
Univ London |
Pharmaceutical preparations for the treatment of ocular surface and other disorders
|
|
FR2869531B1
(fr)
|
2004-04-30 |
2006-07-14 |
Optis France Sa Sa |
Dispositif de iontophorese oculaire diminuant les irritations
|
|
US7264279B2
(en)
|
2004-07-08 |
2007-09-04 |
Fab-Tech, Inc. |
Segmented conduit having a monolithic lining
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US20060188492A1
(en)
|
2005-01-13 |
2006-08-24 |
Chronorx Llc, An Alaska Limited Liability Company |
Topical management of ocular and periocular conditions
|
|
US20060275278A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Choy Camus K M |
Method and ophthalmic formulation for eye protection or treatment
|
|
WO2007011874A2
(en)
|
2005-07-15 |
2007-01-25 |
Chakshu Research Inc. |
Formulation and method for administration of ophthalmologically active agents
|
|
US20070055070A1
(en)
|
2005-09-07 |
2007-03-08 |
Lawrence Lowell J |
Novel esters of lipoic acid
|
|
US20070207116A1
(en)
*
|
2006-03-01 |
2007-09-06 |
Brown David C |
Antioxidant compositions for the eye
|
|
US7973073B2
(en)
|
2006-06-16 |
2011-07-05 |
Indigene Pharmaceuticals, Inc. |
Antidiabetic agent for control of diabetic hyperglycemia and diabetic complications
|
|
WO2008067403A2
(en)
|
2006-11-28 |
2008-06-05 |
Encore Health Llc |
Presbyopia treatment by lens alteration
|
|
BRPI0720000A2
(pt)
*
|
2006-12-08 |
2013-12-17 |
Sachtleben Chemie Gmbh |
Corpo moldado contendo titâno
|
|
DE102006062599B4
(de)
|
2006-12-29 |
2018-03-08 |
Endress + Hauser Gmbh + Co. Kg |
Opto-elektronische Vorrichtung zur Übertragung eines elektrischen Signals und deren Verwendung
|
|
GB2459809A
(en)
|
2007-02-22 |
2009-11-11 |
Children S Hospital And Res Ct |
Fatty acid formulations and methods of use thereof
|
|
US8318795B2
(en)
|
2007-03-01 |
2012-11-27 |
Cedars-Sinai Medical Center |
Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
|
|
UA86441C2
(ru)
|
2007-03-30 |
2009-04-27 |
Акционерное Общество Открытого Типа "Галичфарм" |
(2-гидроксиэтил)триметиламмония тиоктат (холина тиоктат), имеющий гепатопротекторное, гипоаммониемическое и детоксицирующее действие, способ его получения, фармацевтическая композиция на его основе
|
|
CN101848715A
(zh)
*
|
2007-08-09 |
2010-09-29 |
千寿制药株式会社 |
含吡诺克辛的二液性滴眼剂
|
|
WO2009111635A2
(en)
|
2008-03-05 |
2009-09-11 |
Encore Health, Llc |
Dithiol compounds, derivatives, and uses therefor
|
|
US9044439B2
(en)
|
2008-03-05 |
2015-06-02 |
Encore Health, Llc |
Low dose lipoic and pharmaceutical compositions and methods
|
|
DK2442647T3
(en)
|
2009-06-15 |
2016-05-30 |
Encore Health Llc |
Dithiolforbindelser, derivatives thereof, and the uses of these
|
|
EP2442645B1
(en)
|
2009-06-15 |
2014-08-27 |
Encore Health, Llc |
Choline esters
|
|
DE102010009475B4
(de)
*
|
2010-02-26 |
2011-11-24 |
F. Holzer Gmbh |
Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates
|
|
BR112012023421B1
(pt)
|
2010-03-17 |
2021-09-14 |
Novaliq Gmbh |
Composição farmacêutica para tratamento de aumento de pressão intraocular
|
|
MX353154B
(es)
*
|
2011-01-04 |
2017-12-20 |
Novaliq Gmbh |
Emulsiones de aceite/agua que comprenden alcanos semifluorados.
|
|
AU2013211645B2
(en)
*
|
2012-01-23 |
2017-06-15 |
Novaliq Gmbh |
Stabilised protein compositions based on semifluorinated alkanes
|
|
EP3078384A1
(en)
*
|
2012-02-22 |
2016-10-12 |
Stealth Peptides International, Inc. |
Methods and compositions for preventing or treating ophthalmic conditions
|